Drilldown: Medicines
Appearance
Use the filters below to narrow your results.
Monoamine releasing agent (1) ·
Potent 5-HT2A agonist (1) ·
'"`UNIQ--vote-00000B40-QINU`"' The TRANSFORM-HF trial (2023) found no all-cause mortality difference between torsemide and furosemide in heart failure, although torsemide remains pharmacologically preferred where furosemide oral absorption is unreliable'"`UNIQ--ref-00000B41-QINU`"'. (1)
Showing below up to 3 results in range #1 to #3.


